Soleus Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$2.85M Hold
2024
Q1
$6.39M Buy
2022
Q4
Sell
2022
Q3
$1.51M Sell
2022
Q2
$4.82M Sell
2022
Q1
$7.98M Buy
2021
Q4
$456K Buy
2021
Q1
Sell
2020
Q4
$621K Sell
2020
Q3
$388K Sell
2020
Q2
$1.13M Buy
2020
Q1
Sell
2019
Q4
$223K Buy